Dystrogen Therapeutics

0 followers

‌

Dystrogen Therapeutics is a clinical-stage regenerative medicine company focusing on rare diseases. The company is currently testing DEC therapy for Duchenne Muscular Dystrophy.

Industries

Biotechnology

Headquarters

Chicago, United States

Employees

1-10

Links

Org chart

Kris Siemionow

Co-Founder & CEO

Kris Siemionow

Collapse

Maria Siemionow

Founder & CSO

MŻ

Michał Żółtowski

Member Of The Supervisory Board

Teams

Leadership Team

3 members

Similar companies

BeiGene

19 followers

Immunome

2 followers

Abbott

277 followers

Thermo Fisher Scientific

156 followers

Biogen

114 followers

Alexion Pharmaceuticals

34 followers

Cytiva

10 followers

Ascendis Pharma

8 followers

NeoGenomics

8 followers

NBOUND

2 followers

Pendulum

4 followers

Explore companies